Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $7.64M | $23.1M | $31.8M |
| Revenue growth | — | — | — | 201.9% | 37.9% |
| Gross profit | -$3.38M | -$1.97M | -$55.4M | -$2.04M | $6.11M |
| Gross margin | — | — | -725.0% | -8.9% | 19.2% |
| Operating income | -$23.5M | -$69.5M | -$230M | -$243M | -$177M |
| Operating margin | — | — | -3012.2% | -1051.7% | -557.0% |
| Net income | -$39.6M | -$126M | -$214M | -$222M | -$157M |
| Net margin | — | — | -2800.5% | -963.2% | -492.6% |
| EPS (diluted) | -$0.49 | -$1.07 | -$1.30 | -$1.19 | -$0.75 |
| Fiscal year | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$20.1M | -$51.3M | -$105M | -$109M | -$95.3M |
| Capital expenditures | $27.0M | $43.6M | $61.8M | $76.2M | $18.2M |
| Free cash flow | -$47.0M | -$94.9M | -$166M | -$185M | -$114M |
| Share buybacks | $0.00 | $27.0K | $0.00 | $0.00 | $58.4M |
| Fiscal year | FY2020 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $29.1M | $385M | $233M | $273M | $106M |
| Total assets | $65.0M | $483M | $564M | $527M | $879M |
| Total liabilities | $28.7M | $156M | $303M | $278M | $605M |
| Long-term debt | — | — | $169M | $170M | $519M |
| Shareholders' equity | $36.2M | $326M | $258M | $247M | $271M |
| Retained earnings | -$207M | -$333M | -$599M | -$821M | -$978M |
| Shares (wtd avg diluted) | 80.4M | 117M | 170M | 186M | 208M |
Every figure is extracted from Enovix Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.